Likewise, the dimethylarginine dimethylaminohydrolase 1 (DDAH1) gene, which plays an integral role in methylarginine removal, was found to be frequently upregulated in prostate cancer [52], downregulated in gastric cancer [53], and inhibited in attenuated triple negative breast cancer cells [54]. This evidence concerns the gene DDAH1 and prostate cancer.